Skip to content

Feasibility of a Self-Management + Peer Mentoring Intervention for Adolescent and Young Adult Childhood Cancer Survivors

Promoting Follow-Up Care Self-Management for Adolescent and Young Adult (AYA) Childhood Cancer Survivors

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04075734
Enrollment
60
Registered
2019-09-03
Start date
2019-09-01
Completion date
2021-05-26
Last updated
2022-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Childhood Cancer Survivors

Brief summary

The goal of this project is to evaluate the feasibility of the Managing Your Health online self-management skills+peer mentoring intervention that focuses on overcoming survivor barriers to self-management of their survivorship care. We will conduct a pilot randomized controlled trial (RCT) of the intervention versus usual care with adolescent and young adult survivors of childhood cancer ages 18-25 years. Participants will complete survey measures at baseline, Time 2 (about 2 months after baseline), Time 3 (about 5 months after baseline), and Time 4 (about 12 months after baseline).

Detailed description

PRIMARY OBJECTIVES: I. Evaluate the feasibility of the online self-management+peer mentoring program in a pilot RCT. II. Assess preliminary efficacy of the intervention.

Interventions

BEHAVIORALManaging Your Health: Self-Management + Peer Mentoring

The online educational component consists of 5 self-management educational modules: (1) Understanding Your Survivorship Care Plan; (2) Managing Your Healthcare; (3) Family and Significant Other Involvement in Your Healthcare; (4) Emotions about Your Health and Follow-Up Care; (5) Staying Healthy. Participants will be matched with a peer mentor and complete a total of six calls. The first call is to build a rapport and identify the participant's self-management strengths, weaknesses, and goals. The next five calls align with the topic of each module, which the mentee is expected to complete prior to their scheduled call.

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
Rutgers, The State University of New Jersey
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 29 Years
Healthy volunteers
No

Inclusion criteria

Young Adult Survivors: * age 18-25; * at least 2 years from treatment for any pediatric cancer diagnosed at age 0-19; * low self-reported responsibility for healthcare as indicated by reporting parent is primarily responsible for healthcare or low score (1 or 2) on two or more items from Readiness for Transition Questionnaire - Survivor Version. Peer Mentor: * age 21-29; * at least 2 years from treatment for any pediatric cancer diagnosed at age 0-19; * self-reported primary responsibility for healthcare and complete readiness to assume responsibility or high scores (3 or 4) on all items from Readiness for Transition Questionnaire - Survivor Version.

Exclusion criteria

• Documented or self-reported cognitive delay to prevent self-management of healthcare.

Design outcomes

Primary

MeasureTime frameDescription
Acceptance of Peer Mentors (Young Adult Survivors and Peer Mentors): QuestionnaireTime 2, about 2 months since baselineAcceptance will be evaluated by young adult survivors' and peer mentors' report on perceived alliance with each other using the Working Alliance Inventory - Short Form Revised (Hatcher & Gillaspy, 2006), a validated measure of the quality and strength of the relationship. Items are rated on a 5-point scale. The measure yields 3 subscales summary scores that can range from 5 to 20, with higher scores indicating more positive relationships. Sum scores on each sub-scale with be calculated: Bond, Goal, and Task.
Feasibility Measure: Enrollment (Young Adult Survivors) - Number of Eligible Patients Consented and Completing BaselineBaselineDetermined by number of eligible patients consented and completing baseline. Hypothesis: \>50% of eligible will consent and complete the baseline.
Feasibility Measure: Retention in Study (Young Adult Survivors): Percent of Consented Patients Who Are Retained in the Study and Complete Time 3 Follow-upTime 3 at about 5 months since Baseline.Retention in study (Young Adult Survivors). Determined by the percent of consented patients who are retained in the study and complete Time 3 follow-up. Hypothesis: \>80%.
Feasibility: Completion of the Intervention (Young Adult Survivors): PercentageTime 2, about 2 months since baseline.Mean percent completed per task: (a) On-line self-management educational modules and (b) Weekly calls with peer mentor.
Feasibility: Satisfaction With Intervention (Young Adult Survivors): MeanTime 2, about 2 months since baseline.Five items assess satisfaction with each aspect of the intervention: a. Overall program satisfaction; b. Content of online modules; c. Discussions with peer mentor; d. Frequency of calls with peer mentor; and e. Duration of program. First 3 items (a, b and c) were evaluated using a 5-point scale, (Minimum 1, Maximum 5) with higher scores indicating greater satisfaction. Item c evaluated on a scale from 1 not frequent enough to 3 too frequent. Item d uses a 1 way too short to 5 way too long scale. The sample mean will be examined.
Feasibility: Utility of the Online Self-Management Modules (Young Adult Survivors): QuestionnaireTime 2, about 2 months since baseline.The Utility Questionnaire is an 11-item scale that measures perceived ease of use and convenience of the online program using a 5-point scale, (minimum 1, maximum 5) with higher scores indicating greater perceived utility. An overall mean of all items will be calculated.
Feasibility: Impact of the Online Self-Management Modules (Young Adult Survivors): QuestionnaireTime 2, about 2 months since baseline.The Impact Questionnaire is a 13-item scale that measures perceived effectiveness of the online program using a 5-point scale, (minimum 1, and maximum 5) with higher scores indicating greater perceived effectiveness. An overall mean of all items will be calculated.
Feasibility: Adherence Barriers to the Online Self-Management Modules (Young Adult Survivors): QuestionnaireTime 2, about 2 months since baseline.The Adherence Barriers Questionnaire is a 6-item scale that measures perceived barriers to using the online program using a 5-point scale, (minimum 1 and maximum 5) with higher scores indicating greater perceived barriers. An overall mean of all items will be calculated.

Secondary

MeasureTime frameDescription
Self-efficacy for Communicating With Family About Healthcare (Young Adult Survivors): ScaleBaseline, Time 2 (about 2 months since baseline), Time 3 (about 5 months since baseline), Time 4 (about 12 months since baseline).This scale measures confidence in communicating with family about healthcare concerns using a 5-point scale, with higher scores indicating greater confidence. A mean score is calculated (range from 1-5).
Self-efficacy for Managing Late Effects (Young Adult Survivors): ScaleBaseline, Time 2 (about 2 months since baseline), Time 3 (about 5 months since baseline), Time 4 (about 12 months since baseline).This scale consists of three items measuring confidence in managing late effects using a 5-point scale, with higher scores indicating higher confidence. A mean score is calculated (range 1-5).
Health Insurance Self-efficacy (Young Adult Survivors): ScaleBaseline, Time 2 (about 2 months since baseline), Time 3 (about 5 months since baseline), Time 4 (about 12 months since baseline).This scale consists of seven items measuring confidence in managing health insurance using a 5-point scale, with higher scores indicating higher confidence. A mean score is calculated (range 1-5).
Self-efficacy for Managing Emotions (Young Adult Survivors): ScaleBaseline, Time 2 (about 2 months since baseline), Time 3 (about 5 months since baseline)The Patient-Reported Outcomes Measurement Information System (PROMIS) Self-Efficacy for Managing Chronic Conditions - Managing Emotions-Short Form is an 8-item measure of confidence in managing emotions. A mean score will be calculated (range 1-5). Higher scores indicate higher confidence in managing emotions.
Emotional Support (Young Adult Survivors)Baseline, Time 2 (about 2 months since baseline), Time 3 (about 5 months since baseline), Time 4 (about 12 months since baseline).The Patient-Reported Outcomes Measurement Information System (PROMIS) Emotional Support-Short Form is a 4-item measure of perceived emotional support. A mean score will be calculated (range 1-5), with higher scores indicative of having better perceived emotional support.
Informational Support (Young Adult Survivors)Baseline, Time 2 (about 2 months since baseline), Time 3 (about 5 months since baseline), Time 4 (about 12 months since baseline).The Patient-Reported Outcomes Measurement Information System (PROMIS) Informational Support-Short Form is a 4-item measure of perceived availability of helpful information or advice. A mean score will be calculated (range 1-5), with higher scores indicating higher perceived informational support.
Survivorship Care Attitudes (Young Adult Survivors)Baseline, Time 2 (about 2 months since baseline), Time 3 (about 5 months since baseline), Time 4 (about 12 months since baseline).This scale consists of four items measuring attitudes toward survivorship care using a 5-point scale, with higher scores indicating more positive attitudes. A mean score is calculated (range 1-5).
Self-efficacy for Survivorship Care Planning (Young Adult Survivors): ScaleBaseline, Time 2 (about 2 months since baseline), Time 3 (about 5 months since baseline), Time 4 (about 12 months since baseline).This scale consists of three items measuring confidence in survivorship care planning using a 5-point scale, with higher scores indicating higher confidence. A mean score is calculated (range 1-5).
Healthcare Responsibility (Young Adult Survivors)Baseline, Time 2 (about 2 months since baseline), Time 3 (about 5 months since baseline), Time 4 (about 12 months since baseline).The Readiness for Transition Questionnaire - Survivor Version (RTQ) assesses the degree to which survivors are responsible for 10 healthcare behaviors, including knowing their survivorship care plan, scheduling annual visits, scheduling specialist appointments, taking and filling medications (if prescribed), explaining medical history to others, knowing insurance coverage, attending appointments, communicating with providers, and calling providers, on a 4-point scale, with higher scores indicating higher levels of responsibility. The RTQ yields a total mean score for responsibility. It also has one item evaluating overall readiness to assume complete responsibility for healthcare with response options of Not at all ready, somewhat ready, mostly ready, or completely ready. The sample mean for the Total Responsibility score and overall readiness item will be calculated (range 1-4)
Knowledge (Young Adult Survivors)Baseline, Time 2 (about 2 months since baseline), Time 3 (about 5 months since baseline)The knowledge subscale from the Transition Readiness Inventory (TRI) measures knowledge of survivorship care using a 5-point scale, with higher scores indicating greater knowledge. A mean score will be calculated (range 1-5).
Self-Management Skills/Self-Efficacy (Young Adult Survivors)Baseline, Time 2 (about 2 months since baseline), Time 3 (about 5 months since baseline)The Skills/Self-Efficacy sub-scale from the Transition Readiness Inventory (TRI) measures self-management skills and self-efficacy for survivorship care using a 5-point scale, with higher scores indicating greater skills/efficacy. A mean score will be calculated (range 1-5).
Self-Management Goals (Young Adult Survivors)Baseline, Time 2 (about 2 months since baseline), Time 3 (about 5 months since baseline)The Goals subscale from the Transition Readiness Inventory (TRI) measures self-management goals for survivorship care using a 5-point scale, with higher scores indicating greater goals. A mean score will be calculated (range 1-5).
Self-Management Beliefs (Young Adult Survivors)Baseline, Time 2 (about 2 months since baseline), Time 3 (about 5 months since baseline)The Beliefs/Expectations sub-scale from the Transition Readiness Inventory (TRI) measures self-management beliefs for survivorship care using a 5-point scale, with higher scores indicating more positive beliefs. A mean score will be calculated (range 1-5).
Self-efficacy for Communicating With Physician (Young Adult Survivors): ScaleBaseline, Time 2 (about 2 months since baseline), Time 3 (about 5 months since baseline), Time 4 (about 12 months since baseline).This single item measures confidence in communicating with a physician about health concerns using a 10-point scale, with higher scores indicating greater confidence. Range is from 1-10.

Other

MeasureTime frameDescription
Healthcare Utilization (Young Adult Survivors)Baseline, Time 3 (about 5 months since baseline), Time 4 (about 12 months since baseline).As an exploratory outcome, participants will report on receipt of the following healthcare (if applicable): Survivorship Care Plan, annual survivorship visit, echocardiogram within last 5 years, mammogram ever (females only), skin cancer screening ever, primary care visit in last 2 years, dental visit in the last year, annual flu vaccine up-to-date, and human papillomavirus (HPV) vaccine ever. Each item will be treated individually. The number of survivors reporting receipt of each healthcare service will be counted. Yes indicates receipt within time frame indicated for the outcome; No indicates either not received or not due per self-report.

Countries

United States

Participant flow

Participants by arm

ArmCount
RCT Intervention
The intervention consists of (1) online self-management educational modules and (2) weekly peer mentor calls to facilitate engagement with the modules and offer specialized support over approximately six weeks. Managing Your Health: Self-Management + Peer Mentoring: The online educational component consists of 5 self-management educational modules: (1) Understanding Your Survivorship Care Plan; (2) Managing Your Healthcare; (3) Family and Significant Other Involvement in Your Healthcare; (4) Emotions about Your Health and Follow-Up Care; (5) Staying Healthy. Participants will be matched with a peer mentor and complete a total of six calls. The first call is to build a rapport and identify the participant's self-management strengths, weaknesses, and goals. The next five calls align with the topic of each module, which the mentee is expected to complete prior to their scheduled call.
25
RCT Usual Care
Participants receive usual care.
25
Mentors
Peer Mentors were recruited and matched 1:1 with each participant randomized to RCT Intervention to facilitate engagement with the online modules and offer specialized support.
10
Total60

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall StudyLost to Follow-up110
Overall StudyWithdrawal by Subject300

Baseline characteristics

CharacteristicRCT InterventionRCT Usual CareMentorsTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
25 Participants25 Participants10 Participants60 Participants
Age, Continuous21.12 years
STANDARD_DEVIATION 2.03
21.60 years
STANDARD_DEVIATION 1.89
26.50 years
STANDARD_DEVIATION 2.46
23.07 years
STANDARD_DEVIATION 2.13
Ethnicity (NIH/OMB)
Hispanic or Latino
4 Participants1 Participants0 Participants5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
21 Participants24 Participants10 Participants55 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
3 Participants5 Participants1 Participants9 Participants
Race (NIH/OMB)
Black or African American
5 Participants3 Participants0 Participants8 Participants
Race (NIH/OMB)
More than one race
1 Participants2 Participants0 Participants3 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants1 Participants0 Participants1 Participants
Race (NIH/OMB)
White
16 Participants14 Participants9 Participants39 Participants
Region of Enrollment
United States
25 participants25 participants10 participants60 participants
Sex: Female, Male
Female
11 Participants9 Participants5 Participants25 Participants
Sex: Female, Male
Male
14 Participants16 Participants5 Participants35 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 250 / 250 / 10
other
Total, other adverse events
0 / 250 / 250 / 10
serious
Total, serious adverse events
0 / 250 / 250 / 10

Outcome results

Primary

Acceptance of Peer Mentors (Young Adult Survivors and Peer Mentors): Questionnaire

Acceptance will be evaluated by young adult survivors' and peer mentors' report on perceived alliance with each other using the Working Alliance Inventory - Short Form Revised (Hatcher & Gillaspy, 2006), a validated measure of the quality and strength of the relationship. Items are rated on a 5-point scale. The measure yields 3 subscales summary scores that can range from 5 to 20, with higher scores indicating more positive relationships. Sum scores on each sub-scale with be calculated: Bond, Goal, and Task.

Time frame: Time 2, about 2 months since baseline

Population: Peer mentors and young adult survivors in RCT Intervention group who completed the tested intervention (i.e., n=22). Please note, while total number of mentors on study was n=10, total reports by mentors for this measure was n=22 (some mentors were assigned to mentor more than one young adult survivor assigned to RCT intervention group.)

ArmMeasureGroupValue (MEAN)Dispersion
Randomized Control Trial Participants-Young Adult SurvivorsAcceptance of Peer Mentors (Young Adult Survivors and Peer Mentors): QuestionnaireBond18.41 score on a scaleStandard Deviation 1.92
Randomized Control Trial Participants-Young Adult SurvivorsAcceptance of Peer Mentors (Young Adult Survivors and Peer Mentors): QuestionnaireGoal17.68 score on a scaleStandard Deviation 2.28
Randomized Control Trial Participants-Young Adult SurvivorsAcceptance of Peer Mentors (Young Adult Survivors and Peer Mentors): QuestionnaireTask18.14 score on a scaleStandard Deviation 2.01
Usual CareAcceptance of Peer Mentors (Young Adult Survivors and Peer Mentors): QuestionnaireBond19.55 score on a scaleStandard Deviation 1.14
Usual CareAcceptance of Peer Mentors (Young Adult Survivors and Peer Mentors): QuestionnaireGoal13.45 score on a scaleStandard Deviation 1.71
Usual CareAcceptance of Peer Mentors (Young Adult Survivors and Peer Mentors): QuestionnaireTask13.09 score on a scaleStandard Deviation 1.66
Primary

Feasibility: Adherence Barriers to the Online Self-Management Modules (Young Adult Survivors): Questionnaire

The Adherence Barriers Questionnaire is a 6-item scale that measures perceived barriers to using the online program using a 5-point scale, (minimum 1 and maximum 5) with higher scores indicating greater perceived barriers. An overall mean of all items will be calculated.

Time frame: Time 2, about 2 months since baseline.

Population: Data available and reported only for participants who were assigned to this group and completed the tested intervention, i.e., n=22. Total of three participants assigned to this group, withdrew from the study, without completing the tested intervention.

ArmMeasureValue (MEAN)Dispersion
Randomized Control Trial Participants-Young Adult SurvivorsFeasibility: Adherence Barriers to the Online Self-Management Modules (Young Adult Survivors): Questionnaire1.17 score on a scaleStandard Deviation 0.24
Primary

Feasibility: Completion of the Intervention (Young Adult Survivors): Percentage

Mean percent completed per task: (a) On-line self-management educational modules and (b) Weekly calls with peer mentor.

Time frame: Time 2, about 2 months since baseline.

Population: Data available and reported only for participants who were assigned to this group and completed the tested intervention, i.e., n=22. Total of three participants assigned to this group, withdrew from the study, without completing the tested intervention.

ArmMeasureGroupValue (MEAN)
Randomized Control Trial Participants-Young Adult SurvivorsFeasibility: Completion of the Intervention (Young Adult Survivors): PercentageOn-line self-management educational modules95.72 percent completed
Randomized Control Trial Participants-Young Adult SurvivorsFeasibility: Completion of the Intervention (Young Adult Survivors): PercentageWeekly calls with peer mentor97.72 percent completed
Primary

Feasibility: Impact of the Online Self-Management Modules (Young Adult Survivors): Questionnaire

The Impact Questionnaire is a 13-item scale that measures perceived effectiveness of the online program using a 5-point scale, (minimum 1, and maximum 5) with higher scores indicating greater perceived effectiveness. An overall mean of all items will be calculated.

Time frame: Time 2, about 2 months since baseline.

Population: Data available and reported only for participants who were assigned to this group and completed the tested intervention, i.e., n=22. Total of three participants assigned to this group, withdrew from the study, without completing the tested intervention.

ArmMeasureValue (MEAN)Dispersion
Randomized Control Trial Participants-Young Adult SurvivorsFeasibility: Impact of the Online Self-Management Modules (Young Adult Survivors): Questionnaire4.29 score on a scaleStandard Deviation 0.48
Primary

Feasibility Measure: Enrollment (Young Adult Survivors) - Number of Eligible Patients Consented and Completing Baseline

Determined by number of eligible patients consented and completing baseline. Hypothesis: \>50% of eligible will consent and complete the baseline.

Time frame: Baseline

Population: All potentially eligible participants identified by the New Jersey State Cancer Registry (NJSCR) and approached at the local Long-Term Information Treatment Evaluation (LITE) program by study staff.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Randomized Control Trial Participants-Young Adult SurvivorsFeasibility Measure: Enrollment (Young Adult Survivors) - Number of Eligible Patients Consented and Completing BaselineEnrolled50 Participants
Randomized Control Trial Participants-Young Adult SurvivorsFeasibility Measure: Enrollment (Young Adult Survivors) - Number of Eligible Patients Consented and Completing BaselineNot Interested29 Participants
Primary

Feasibility Measure: Retention in Study (Young Adult Survivors): Percent of Consented Patients Who Are Retained in the Study and Complete Time 3 Follow-up

Retention in study (Young Adult Survivors). Determined by the percent of consented patients who are retained in the study and complete Time 3 follow-up. Hypothesis: \>80%.

Time frame: Time 3 at about 5 months since Baseline.

Population: Young Adult Survivors who enrolled on study, i.e., consented and completed baseline.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Randomized Control Trial Participants-Young Adult SurvivorsFeasibility Measure: Retention in Study (Young Adult Survivors): Percent of Consented Patients Who Are Retained in the Study and Complete Time 3 Follow-up22 Participants
Usual CareFeasibility Measure: Retention in Study (Young Adult Survivors): Percent of Consented Patients Who Are Retained in the Study and Complete Time 3 Follow-up25 Participants
Primary

Feasibility: Satisfaction With Intervention (Young Adult Survivors): Mean

Five items assess satisfaction with each aspect of the intervention: a. Overall program satisfaction; b. Content of online modules; c. Discussions with peer mentor; d. Frequency of calls with peer mentor; and e. Duration of program. First 3 items (a, b and c) were evaluated using a 5-point scale, (Minimum 1, Maximum 5) with higher scores indicating greater satisfaction. Item c evaluated on a scale from 1 not frequent enough to 3 too frequent. Item d uses a 1 way too short to 5 way too long scale. The sample mean will be examined.

Time frame: Time 2, about 2 months since baseline.

Population: Data available and reported only for participants who were assigned to this group and completed the tested intervention, i.e., n=22. Total of three participants assigned to this group, withdrew from the study, without completing the tested intervention.

ArmMeasureGroupValue (MEAN)Dispersion
Randomized Control Trial Participants-Young Adult SurvivorsFeasibility: Satisfaction With Intervention (Young Adult Survivors): Meana. Satisfaction w/ Program overall [Scale 1-5]4.64 score on a scaleStandard Deviation 0.49
Randomized Control Trial Participants-Young Adult SurvivorsFeasibility: Satisfaction With Intervention (Young Adult Survivors): Meanb. Satisfaction w/ Content of online modules [Scale 1-5]4.41 score on a scaleStandard Deviation 0.59
Randomized Control Trial Participants-Young Adult SurvivorsFeasibility: Satisfaction With Intervention (Young Adult Survivors): Meanc. Satisfaction w/ Discussions with peer mentor [Scale 1-5]4.64 score on a scaleStandard Deviation 0.49
Randomized Control Trial Participants-Young Adult SurvivorsFeasibility: Satisfaction With Intervention (Young Adult Survivors): Meand. Satisfaction w/ Frequency of calls with peer mentor [Scale 1-3; 2=Just right]2.00 score on a scaleStandard Deviation 0.31
Randomized Control Trial Participants-Young Adult SurvivorsFeasibility: Satisfaction With Intervention (Young Adult Survivors): Meane. Satisfaction w/ Duration of program [Scale 1-5; 3= Just right2.86 score on a scaleStandard Deviation 0.47
Primary

Feasibility: Utility of the Online Self-Management Modules (Young Adult Survivors): Questionnaire

The Utility Questionnaire is an 11-item scale that measures perceived ease of use and convenience of the online program using a 5-point scale, (minimum 1, maximum 5) with higher scores indicating greater perceived utility. An overall mean of all items will be calculated.

Time frame: Time 2, about 2 months since baseline.

Population: Data available and reported only for participants who were assigned to this group and completed the tested intervention, i.e., n=22. Total of three participants assigned to this group, withdrew from the study, without completing the tested intervention.

ArmMeasureValue (MEAN)Dispersion
Randomized Control Trial Participants-Young Adult SurvivorsFeasibility: Utility of the Online Self-Management Modules (Young Adult Survivors): Questionnaire4.35 score on a scaleStandard Deviation 0.54
Secondary

Emotional Support (Young Adult Survivors)

The Patient-Reported Outcomes Measurement Information System (PROMIS) Emotional Support-Short Form is a 4-item measure of perceived emotional support. A mean score will be calculated (range 1-5), with higher scores indicative of having better perceived emotional support.

Time frame: Baseline, Time 2 (about 2 months since baseline), Time 3 (about 5 months since baseline), Time 4 (about 12 months since baseline).

ArmMeasureGroupValue (MEAN)Dispersion
Randomized Control Trial Participants-Young Adult SurvivorsEmotional Support (Young Adult Survivors)Baseline4.18 score on a scaleStandard Deviation 0.98
Randomized Control Trial Participants-Young Adult SurvivorsEmotional Support (Young Adult Survivors)Time 24.36 score on a scaleStandard Deviation 1.04
Randomized Control Trial Participants-Young Adult SurvivorsEmotional Support (Young Adult Survivors)Time 34.3 score on a scaleStandard Deviation 1.09
Randomized Control Trial Participants-Young Adult SurvivorsEmotional Support (Young Adult Survivors)Time 44.42 score on a scaleStandard Deviation 0.75
Usual CareEmotional Support (Young Adult Survivors)Time 44.57 score on a scaleStandard Deviation 0.63
Usual CareEmotional Support (Young Adult Survivors)Baseline4.47 score on a scaleStandard Deviation 0.77
Usual CareEmotional Support (Young Adult Survivors)Time 34.5 score on a scaleStandard Deviation 0.68
Usual CareEmotional Support (Young Adult Survivors)Time 24.5 score on a scaleStandard Deviation 0.76
p-value: 0.66Mixed Models Analysis
Secondary

Healthcare Responsibility (Young Adult Survivors)

The Readiness for Transition Questionnaire - Survivor Version (RTQ) assesses the degree to which survivors are responsible for 10 healthcare behaviors, including knowing their survivorship care plan, scheduling annual visits, scheduling specialist appointments, taking and filling medications (if prescribed), explaining medical history to others, knowing insurance coverage, attending appointments, communicating with providers, and calling providers, on a 4-point scale, with higher scores indicating higher levels of responsibility. The RTQ yields a total mean score for responsibility. It also has one item evaluating overall readiness to assume complete responsibility for healthcare with response options of Not at all ready, somewhat ready, mostly ready, or completely ready. The sample mean for the Total Responsibility score and overall readiness item will be calculated (range 1-4)

Time frame: Baseline, Time 2 (about 2 months since baseline), Time 3 (about 5 months since baseline), Time 4 (about 12 months since baseline).

ArmMeasureGroupValue (MEAN)Dispersion
Randomized Control Trial Participants-Young Adult SurvivorsHealthcare Responsibility (Young Adult Survivors)Baseline RTQ Total2.73 score on a scaleStandard Deviation 0.63
Randomized Control Trial Participants-Young Adult SurvivorsHealthcare Responsibility (Young Adult Survivors)Time 2 RTQ Total3.1 score on a scaleStandard Deviation 0.67
Randomized Control Trial Participants-Young Adult SurvivorsHealthcare Responsibility (Young Adult Survivors)Time 3 RTQ Total3.02 score on a scaleStandard Deviation 0.72
Randomized Control Trial Participants-Young Adult SurvivorsHealthcare Responsibility (Young Adult Survivors)Time 4 RTQ Total3.16 score on a scaleStandard Deviation 0.64
Randomized Control Trial Participants-Young Adult SurvivorsHealthcare Responsibility (Young Adult Survivors)Baseline RTQ Overall readiness2.36 score on a scaleStandard Deviation 0.76
Randomized Control Trial Participants-Young Adult SurvivorsHealthcare Responsibility (Young Adult Survivors)Time 2 RTQ Overall readiness2.64 score on a scaleStandard Deviation 0.85
Randomized Control Trial Participants-Young Adult SurvivorsHealthcare Responsibility (Young Adult Survivors)Time 3 RTQ Overall readiness2.86 score on a scaleStandard Deviation 0.77
Randomized Control Trial Participants-Young Adult SurvivorsHealthcare Responsibility (Young Adult Survivors)Time 4 RTQ Overall readiness3.14 score on a scaleStandard Deviation 0.79
Usual CareHealthcare Responsibility (Young Adult Survivors)Time 4 RTQ Overall readiness3.04 score on a scaleStandard Deviation 0.95
Usual CareHealthcare Responsibility (Young Adult Survivors)Baseline RTQ Total2.83 score on a scaleStandard Deviation 0.54
Usual CareHealthcare Responsibility (Young Adult Survivors)Baseline RTQ Overall readiness2.8 score on a scaleStandard Deviation 0.96
Usual CareHealthcare Responsibility (Young Adult Survivors)Time 2 RTQ Total3.08 score on a scaleStandard Deviation 0.49
Usual CareHealthcare Responsibility (Young Adult Survivors)Time 3 RTQ Overall readiness2.8 score on a scaleStandard Deviation 0.91
Usual CareHealthcare Responsibility (Young Adult Survivors)Time 3 RTQ Total3.07 score on a scaleStandard Deviation 0.64
Usual CareHealthcare Responsibility (Young Adult Survivors)Time 2 RTQ Overall readiness2.76 score on a scaleStandard Deviation 0.97
Usual CareHealthcare Responsibility (Young Adult Survivors)Time 4 RTQ Total3.23 score on a scaleStandard Deviation 0.63
p-value: 0.59Mixed Models Analysis
p-value: 0.003Mixed Models Analysis
Secondary

Health Insurance Self-efficacy (Young Adult Survivors): Scale

This scale consists of seven items measuring confidence in managing health insurance using a 5-point scale, with higher scores indicating higher confidence. A mean score is calculated (range 1-5).

Time frame: Baseline, Time 2 (about 2 months since baseline), Time 3 (about 5 months since baseline), Time 4 (about 12 months since baseline).

ArmMeasureGroupValue (MEAN)Dispersion
Randomized Control Trial Participants-Young Adult SurvivorsHealth Insurance Self-efficacy (Young Adult Survivors): ScaleBaseline2.2 score on a scaleStandard Deviation 0.88
Randomized Control Trial Participants-Young Adult SurvivorsHealth Insurance Self-efficacy (Young Adult Survivors): ScaleTime 23.06 score on a scaleStandard Deviation 1.25
Randomized Control Trial Participants-Young Adult SurvivorsHealth Insurance Self-efficacy (Young Adult Survivors): ScaleTime 33.45 score on a scaleStandard Deviation 1.19
Randomized Control Trial Participants-Young Adult SurvivorsHealth Insurance Self-efficacy (Young Adult Survivors): ScaleTime 43.36 score on a scaleStandard Deviation 0.84
Usual CareHealth Insurance Self-efficacy (Young Adult Survivors): ScaleTime 43.43 score on a scaleStandard Deviation 1.17
Usual CareHealth Insurance Self-efficacy (Young Adult Survivors): ScaleBaseline2.8 score on a scaleStandard Deviation 1.22
Usual CareHealth Insurance Self-efficacy (Young Adult Survivors): ScaleTime 33.55 score on a scaleStandard Deviation 1.13
Usual CareHealth Insurance Self-efficacy (Young Adult Survivors): ScaleTime 23.01 score on a scaleStandard Deviation 1.18
p-value: 0.13Mixed Models Analysis
Secondary

Informational Support (Young Adult Survivors)

The Patient-Reported Outcomes Measurement Information System (PROMIS) Informational Support-Short Form is a 4-item measure of perceived availability of helpful information or advice. A mean score will be calculated (range 1-5), with higher scores indicating higher perceived informational support.

Time frame: Baseline, Time 2 (about 2 months since baseline), Time 3 (about 5 months since baseline), Time 4 (about 12 months since baseline).

ArmMeasureGroupValue (MEAN)Dispersion
Randomized Control Trial Participants-Young Adult SurvivorsInformational Support (Young Adult Survivors)Baseline3.99 score on a scaleStandard Deviation 0.94
Randomized Control Trial Participants-Young Adult SurvivorsInformational Support (Young Adult Survivors)Time 24.41 score on a scaleStandard Deviation 0.97
Randomized Control Trial Participants-Young Adult SurvivorsInformational Support (Young Adult Survivors)Time 44.31 score on a scaleStandard Deviation 0.71
Randomized Control Trial Participants-Young Adult SurvivorsInformational Support (Young Adult Survivors)Time 34.23 score on a scaleStandard Deviation 1.05
Usual CareInformational Support (Young Adult Survivors)Time 44.29 score on a scaleStandard Deviation 0.87
Usual CareInformational Support (Young Adult Survivors)Baseline4.35 score on a scaleStandard Deviation 0.68
Usual CareInformational Support (Young Adult Survivors)Time 24.4 score on a scaleStandard Deviation 0.74
Usual CareInformational Support (Young Adult Survivors)Time 34.43 score on a scaleStandard Deviation 0.71
p-value: 0.15Mixed Models Analysis
Secondary

Knowledge (Young Adult Survivors)

The knowledge subscale from the Transition Readiness Inventory (TRI) measures knowledge of survivorship care using a 5-point scale, with higher scores indicating greater knowledge. A mean score will be calculated (range 1-5).

Time frame: Baseline, Time 2 (about 2 months since baseline), Time 3 (about 5 months since baseline)

ArmMeasureGroupValue (MEAN)Dispersion
Randomized Control Trial Participants-Young Adult SurvivorsKnowledge (Young Adult Survivors)Baseline3.44 score on a scaleStandard Deviation 0.71
Randomized Control Trial Participants-Young Adult SurvivorsKnowledge (Young Adult Survivors)Time 24.1 score on a scaleStandard Deviation 0.67
Randomized Control Trial Participants-Young Adult SurvivorsKnowledge (Young Adult Survivors)Time 34.4 score on a scaleStandard Deviation 0.7
Usual CareKnowledge (Young Adult Survivors)Baseline3.9 score on a scaleStandard Deviation 0.76
Usual CareKnowledge (Young Adult Survivors)Time 24.13 score on a scaleStandard Deviation 0.68
Usual CareKnowledge (Young Adult Survivors)Time 34.45 score on a scaleStandard Deviation 0.77
p-value: 0.03Mixed Models Analysis
Secondary

Self-efficacy for Communicating With Family About Healthcare (Young Adult Survivors): Scale

This scale measures confidence in communicating with family about healthcare concerns using a 5-point scale, with higher scores indicating greater confidence. A mean score is calculated (range from 1-5).

Time frame: Baseline, Time 2 (about 2 months since baseline), Time 3 (about 5 months since baseline), Time 4 (about 12 months since baseline).

ArmMeasureGroupValue (MEAN)Dispersion
Randomized Control Trial Participants-Young Adult SurvivorsSelf-efficacy for Communicating With Family About Healthcare (Young Adult Survivors): ScaleTime 33.91 score on a scaleStandard Deviation 1.23
Randomized Control Trial Participants-Young Adult SurvivorsSelf-efficacy for Communicating With Family About Healthcare (Young Adult Survivors): ScaleBaseline3.49 score on a scaleStandard Deviation 1.04
Randomized Control Trial Participants-Young Adult SurvivorsSelf-efficacy for Communicating With Family About Healthcare (Young Adult Survivors): ScaleTime 44.29 score on a scaleStandard Deviation 0.89
Randomized Control Trial Participants-Young Adult SurvivorsSelf-efficacy for Communicating With Family About Healthcare (Young Adult Survivors): ScaleTime 24.08 score on a scaleStandard Deviation 1.03
Usual CareSelf-efficacy for Communicating With Family About Healthcare (Young Adult Survivors): ScaleTime 44.19 score on a scaleStandard Deviation 0.92
Usual CareSelf-efficacy for Communicating With Family About Healthcare (Young Adult Survivors): ScaleBaseline3.96 score on a scaleStandard Deviation 1.03
Usual CareSelf-efficacy for Communicating With Family About Healthcare (Young Adult Survivors): ScaleTime 34.36 score on a scaleStandard Deviation 1.03
Usual CareSelf-efficacy for Communicating With Family About Healthcare (Young Adult Survivors): ScaleTime 24.09 score on a scaleStandard Deviation 1.15
p-value: 0.14Mixed Models Analysis
Secondary

Self-efficacy for Communicating With Physician (Young Adult Survivors): Scale

This single item measures confidence in communicating with a physician about health concerns using a 10-point scale, with higher scores indicating greater confidence. Range is from 1-10.

Time frame: Baseline, Time 2 (about 2 months since baseline), Time 3 (about 5 months since baseline), Time 4 (about 12 months since baseline).

ArmMeasureGroupValue (MEAN)Dispersion
Randomized Control Trial Participants-Young Adult SurvivorsSelf-efficacy for Communicating With Physician (Young Adult Survivors): ScaleBaseline7.89 score on a scaleStandard Deviation 1.76
Randomized Control Trial Participants-Young Adult SurvivorsSelf-efficacy for Communicating With Physician (Young Adult Survivors): ScaleTime 28.74 score on a scaleStandard Deviation 1.2
Randomized Control Trial Participants-Young Adult SurvivorsSelf-efficacy for Communicating With Physician (Young Adult Survivors): ScaleTime 38.56 score on a scaleStandard Deviation 1.35
Randomized Control Trial Participants-Young Adult SurvivorsSelf-efficacy for Communicating With Physician (Young Adult Survivors): ScaleTime 48.67 score on a scaleStandard Deviation 1.19
Usual CareSelf-efficacy for Communicating With Physician (Young Adult Survivors): ScaleTime 49.0 score on a scaleStandard Deviation 1.27
Usual CareSelf-efficacy for Communicating With Physician (Young Adult Survivors): ScaleBaseline8.28 score on a scaleStandard Deviation 2.16
Usual CareSelf-efficacy for Communicating With Physician (Young Adult Survivors): ScaleTime 38.92 score on a scaleStandard Deviation 1.88
Usual CareSelf-efficacy for Communicating With Physician (Young Adult Survivors): ScaleTime 28.82 score on a scaleStandard Deviation 1.77
p-value: 0.86Mixed Models Analysis
Secondary

Self-efficacy for Managing Emotions (Young Adult Survivors): Scale

The Patient-Reported Outcomes Measurement Information System (PROMIS) Self-Efficacy for Managing Chronic Conditions - Managing Emotions-Short Form is an 8-item measure of confidence in managing emotions. A mean score will be calculated (range 1-5). Higher scores indicate higher confidence in managing emotions.

Time frame: Baseline, Time 2 (about 2 months since baseline), Time 3 (about 5 months since baseline)

ArmMeasureGroupValue (MEAN)Dispersion
Randomized Control Trial Participants-Young Adult SurvivorsSelf-efficacy for Managing Emotions (Young Adult Survivors): ScaleBaseline3.39 score on a scaleStandard Deviation 0.9
Randomized Control Trial Participants-Young Adult SurvivorsSelf-efficacy for Managing Emotions (Young Adult Survivors): ScaleTime 23.85 score on a scaleStandard Deviation 0.94
Randomized Control Trial Participants-Young Adult SurvivorsSelf-efficacy for Managing Emotions (Young Adult Survivors): ScaleTime 33.97 score on a scaleStandard Deviation 0.82
Usual CareSelf-efficacy for Managing Emotions (Young Adult Survivors): ScaleBaseline3.73 score on a scaleStandard Deviation 0.87
Usual CareSelf-efficacy for Managing Emotions (Young Adult Survivors): ScaleTime 23.73 score on a scaleStandard Deviation 0.88
Usual CareSelf-efficacy for Managing Emotions (Young Adult Survivors): ScaleTime 33.86 score on a scaleStandard Deviation 0.76
p-value: 0.03Mixed Models Analysis
Secondary

Self-efficacy for Managing Late Effects (Young Adult Survivors): Scale

This scale consists of three items measuring confidence in managing late effects using a 5-point scale, with higher scores indicating higher confidence. A mean score is calculated (range 1-5).

Time frame: Baseline, Time 2 (about 2 months since baseline), Time 3 (about 5 months since baseline), Time 4 (about 12 months since baseline).

ArmMeasureGroupValue (MEAN)Dispersion
Randomized Control Trial Participants-Young Adult SurvivorsSelf-efficacy for Managing Late Effects (Young Adult Survivors): ScaleBaseline2.39 score on a scaleStandard Deviation 1
Randomized Control Trial Participants-Young Adult SurvivorsSelf-efficacy for Managing Late Effects (Young Adult Survivors): ScaleTime 23.43 score on a scaleStandard Deviation 1.12
Randomized Control Trial Participants-Young Adult SurvivorsSelf-efficacy for Managing Late Effects (Young Adult Survivors): ScaleTime 33.67 score on a scaleStandard Deviation 0.97
Randomized Control Trial Participants-Young Adult SurvivorsSelf-efficacy for Managing Late Effects (Young Adult Survivors): ScaleTime 43.7 score on a scaleStandard Deviation 0.87
Usual CareSelf-efficacy for Managing Late Effects (Young Adult Survivors): ScaleTime 43.54 score on a scaleStandard Deviation 1.27
Usual CareSelf-efficacy for Managing Late Effects (Young Adult Survivors): ScaleBaseline3.05 score on a scaleStandard Deviation 1.35
Usual CareSelf-efficacy for Managing Late Effects (Young Adult Survivors): ScaleTime 33.65 score on a scaleStandard Deviation 1.14
Usual CareSelf-efficacy for Managing Late Effects (Young Adult Survivors): ScaleTime 23.63 score on a scaleStandard Deviation 1.18
p-value: 0.02Mixed Models Analysis
Secondary

Self-efficacy for Survivorship Care Planning (Young Adult Survivors): Scale

This scale consists of three items measuring confidence in survivorship care planning using a 5-point scale, with higher scores indicating higher confidence. A mean score is calculated (range 1-5).

Time frame: Baseline, Time 2 (about 2 months since baseline), Time 3 (about 5 months since baseline), Time 4 (about 12 months since baseline).

ArmMeasureGroupValue (MEAN)Dispersion
Randomized Control Trial Participants-Young Adult SurvivorsSelf-efficacy for Survivorship Care Planning (Young Adult Survivors): ScaleBaseline2.83 score on a scaleStandard Deviation 1.21
Randomized Control Trial Participants-Young Adult SurvivorsSelf-efficacy for Survivorship Care Planning (Young Adult Survivors): ScaleTime 23.89 score on a scaleStandard Deviation 0.89
Randomized Control Trial Participants-Young Adult SurvivorsSelf-efficacy for Survivorship Care Planning (Young Adult Survivors): ScaleTime 33.92 score on a scaleStandard Deviation 1.15
Randomized Control Trial Participants-Young Adult SurvivorsSelf-efficacy for Survivorship Care Planning (Young Adult Survivors): ScaleTime 44.1 score on a scaleStandard Deviation 0.84
Usual CareSelf-efficacy for Survivorship Care Planning (Young Adult Survivors): ScaleTime 43.96 score on a scaleStandard Deviation 1.18
Usual CareSelf-efficacy for Survivorship Care Planning (Young Adult Survivors): ScaleBaseline3.25 score on a scaleStandard Deviation 1.53
Usual CareSelf-efficacy for Survivorship Care Planning (Young Adult Survivors): ScaleTime 33.96 score on a scaleStandard Deviation 1.33
Usual CareSelf-efficacy for Survivorship Care Planning (Young Adult Survivors): ScaleTime 23.65 score on a scaleStandard Deviation 1.28
p-value: 0.29Mixed Models Analysis
Secondary

Self-Management Beliefs (Young Adult Survivors)

The Beliefs/Expectations sub-scale from the Transition Readiness Inventory (TRI) measures self-management beliefs for survivorship care using a 5-point scale, with higher scores indicating more positive beliefs. A mean score will be calculated (range 1-5).

Time frame: Baseline, Time 2 (about 2 months since baseline), Time 3 (about 5 months since baseline)

ArmMeasureGroupValue (MEAN)Dispersion
Randomized Control Trial Participants-Young Adult SurvivorsSelf-Management Beliefs (Young Adult Survivors)Time 34.21 score on a scaleStandard Deviation 0.55
Randomized Control Trial Participants-Young Adult SurvivorsSelf-Management Beliefs (Young Adult Survivors)Baseline3.59 score on a scaleStandard Deviation 0.58
Randomized Control Trial Participants-Young Adult SurvivorsSelf-Management Beliefs (Young Adult Survivors)Time 24.14 score on a scaleStandard Deviation 0.45
Usual CareSelf-Management Beliefs (Young Adult Survivors)Time 24.06 score on a scaleStandard Deviation 0.66
Usual CareSelf-Management Beliefs (Young Adult Survivors)Baseline3.95 score on a scaleStandard Deviation 0.64
Usual CareSelf-Management Beliefs (Young Adult Survivors)Time 34.13 score on a scaleStandard Deviation 0.67
p-value: 0.006Mixed Models Analysis
Secondary

Self-Management Goals (Young Adult Survivors)

The Goals subscale from the Transition Readiness Inventory (TRI) measures self-management goals for survivorship care using a 5-point scale, with higher scores indicating greater goals. A mean score will be calculated (range 1-5).

Time frame: Baseline, Time 2 (about 2 months since baseline), Time 3 (about 5 months since baseline)

ArmMeasureGroupValue (MEAN)Dispersion
Randomized Control Trial Participants-Young Adult SurvivorsSelf-Management Goals (Young Adult Survivors)Baseline3.44 score on a scaleStandard Deviation 0.91
Randomized Control Trial Participants-Young Adult SurvivorsSelf-Management Goals (Young Adult Survivors)Time 24.10 score on a scaleStandard Deviation 0.71
Randomized Control Trial Participants-Young Adult SurvivorsSelf-Management Goals (Young Adult Survivors)Time 34.06 score on a scaleStandard Deviation 0.67
Usual CareSelf-Management Goals (Young Adult Survivors)Baseline3.99 score on a scaleStandard Deviation 1
Usual CareSelf-Management Goals (Young Adult Survivors)Time 24.30 score on a scaleStandard Deviation 0.72
Usual CareSelf-Management Goals (Young Adult Survivors)Time 34.30 score on a scaleStandard Deviation 0.89
p-value: 0.2Mixed Models Analysis
Secondary

Self-Management Skills/Self-Efficacy (Young Adult Survivors)

The Skills/Self-Efficacy sub-scale from the Transition Readiness Inventory (TRI) measures self-management skills and self-efficacy for survivorship care using a 5-point scale, with higher scores indicating greater skills/efficacy. A mean score will be calculated (range 1-5).

Time frame: Baseline, Time 2 (about 2 months since baseline), Time 3 (about 5 months since baseline)

ArmMeasureGroupValue (MEAN)Dispersion
Randomized Control Trial Participants-Young Adult SurvivorsSelf-Management Skills/Self-Efficacy (Young Adult Survivors)Baseline3.4 score on a scaleStandard Deviation 0.68
Randomized Control Trial Participants-Young Adult SurvivorsSelf-Management Skills/Self-Efficacy (Young Adult Survivors)Time 23.72 score on a scaleStandard Deviation 0.78
Randomized Control Trial Participants-Young Adult SurvivorsSelf-Management Skills/Self-Efficacy (Young Adult Survivors)Time 33.84 score on a scaleStandard Deviation 0.76
Usual CareSelf-Management Skills/Self-Efficacy (Young Adult Survivors)Baseline3.81 score on a scaleStandard Deviation 0.71
Usual CareSelf-Management Skills/Self-Efficacy (Young Adult Survivors)Time 23.92 score on a scaleStandard Deviation 0.66
Usual CareSelf-Management Skills/Self-Efficacy (Young Adult Survivors)Time 34.00 score on a scaleStandard Deviation 0.77
p-value: 0.07Mixed Models Analysis
Secondary

Survivorship Care Attitudes (Young Adult Survivors)

This scale consists of four items measuring attitudes toward survivorship care using a 5-point scale, with higher scores indicating more positive attitudes. A mean score is calculated (range 1-5).

Time frame: Baseline, Time 2 (about 2 months since baseline), Time 3 (about 5 months since baseline), Time 4 (about 12 months since baseline).

ArmMeasureGroupValue (MEAN)Dispersion
Randomized Control Trial Participants-Young Adult SurvivorsSurvivorship Care Attitudes (Young Adult Survivors)Baseline4.07 score on a scaleStandard Deviation 0.62
Randomized Control Trial Participants-Young Adult SurvivorsSurvivorship Care Attitudes (Young Adult Survivors)Time 24.35 score on a scaleStandard Deviation 0.66
Randomized Control Trial Participants-Young Adult SurvivorsSurvivorship Care Attitudes (Young Adult Survivors)Time 34.43 score on a scaleStandard Deviation 0.57
Randomized Control Trial Participants-Young Adult SurvivorsSurvivorship Care Attitudes (Young Adult Survivors)Time 44.54 score on a scaleStandard Deviation 0.41
Usual CareSurvivorship Care Attitudes (Young Adult Survivors)Time 44.2 score on a scaleStandard Deviation 0.74
Usual CareSurvivorship Care Attitudes (Young Adult Survivors)Baseline3.99 score on a scaleStandard Deviation 0.76
Usual CareSurvivorship Care Attitudes (Young Adult Survivors)Time 34.25 score on a scaleStandard Deviation 0.73
Usual CareSurvivorship Care Attitudes (Young Adult Survivors)Time 24.03 score on a scaleStandard Deviation 0.93
p-value: 0.14Mixed Models Analysis
Other Pre-specified

Healthcare Utilization (Young Adult Survivors)

As an exploratory outcome, participants will report on receipt of the following healthcare (if applicable): Survivorship Care Plan, annual survivorship visit, echocardiogram within last 5 years, mammogram ever (females only), skin cancer screening ever, primary care visit in last 2 years, dental visit in the last year, annual flu vaccine up-to-date, and human papillomavirus (HPV) vaccine ever. Each item will be treated individually. The number of survivors reporting receipt of each healthcare service will be counted. Yes indicates receipt within time frame indicated for the outcome; No indicates either not received or not due per self-report.

Time frame: Baseline, Time 3 (about 5 months since baseline), Time 4 (about 12 months since baseline).

Population: Mammogram measure was only administered to females so the sample size for those analyses represent the number of females in each arm.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Randomized Control Trial Participants-Young Adult SurvivorsHealthcare Utilization (Young Adult Survivors)Survivorship Care Plan-Time 3 : yes18 Participants
Randomized Control Trial Participants-Young Adult SurvivorsHealthcare Utilization (Young Adult Survivors)Skin cancer screening-Baseline: yes8 Participants
Randomized Control Trial Participants-Young Adult SurvivorsHealthcare Utilization (Young Adult Survivors)Annual survivorship visit-Time 4: yes15 Participants
Randomized Control Trial Participants-Young Adult SurvivorsHealthcare Utilization (Young Adult Survivors)Skin cancer screening-Time 3: yes6 Participants
Randomized Control Trial Participants-Young Adult SurvivorsHealthcare Utilization (Young Adult Survivors)Primary care visit-Baseline: yes21 Participants
Randomized Control Trial Participants-Young Adult SurvivorsHealthcare Utilization (Young Adult Survivors)Skin cancer screening-Time 4: yes8 Participants
Randomized Control Trial Participants-Young Adult SurvivorsHealthcare Utilization (Young Adult Survivors)Echocardiogram-Baseline: yes19 Participants
Randomized Control Trial Participants-Young Adult SurvivorsHealthcare Utilization (Young Adult Survivors)Annual survivorship visit-Time 3: yes6 Participants
Randomized Control Trial Participants-Young Adult SurvivorsHealthcare Utilization (Young Adult Survivors)Primary care visit-Time 3: yes16 Participants
Randomized Control Trial Participants-Young Adult SurvivorsHealthcare Utilization (Young Adult Survivors)Echocardiogram-Time 3: yes19 Participants
Randomized Control Trial Participants-Young Adult SurvivorsHealthcare Utilization (Young Adult Survivors)Primary care visit-Time 4: yes19 Participants
Randomized Control Trial Participants-Young Adult SurvivorsHealthcare Utilization (Young Adult Survivors)Survivorship Care Plan-Time 4 : yes18 Participants
Randomized Control Trial Participants-Young Adult SurvivorsHealthcare Utilization (Young Adult Survivors)Dental visit-Baseline: yes20 Participants
Randomized Control Trial Participants-Young Adult SurvivorsHealthcare Utilization (Young Adult Survivors)Echocardiogram-Time 4: yes18 Participants
Randomized Control Trial Participants-Young Adult SurvivorsHealthcare Utilization (Young Adult Survivors)Dental visit-Time 3: yes20 Participants
Randomized Control Trial Participants-Young Adult SurvivorsHealthcare Utilization (Young Adult Survivors)Annual flu vaccine-Baseline14 Participants
Randomized Control Trial Participants-Young Adult SurvivorsHealthcare Utilization (Young Adult Survivors)Survivorship Care Plan-Baseline : yes9 Participants
Randomized Control Trial Participants-Young Adult SurvivorsHealthcare Utilization (Young Adult Survivors)Annual flu vaccine-Time 318 Participants
Randomized Control Trial Participants-Young Adult SurvivorsHealthcare Utilization (Young Adult Survivors)Mammogram-Baseline: yes1 Participants
Randomized Control Trial Participants-Young Adult SurvivorsHealthcare Utilization (Young Adult Survivors)Annual flu vaccine-Time 415 Participants
Randomized Control Trial Participants-Young Adult SurvivorsHealthcare Utilization (Young Adult Survivors)Annual survivorship visit-Baseline: yes20 Participants
Randomized Control Trial Participants-Young Adult SurvivorsHealthcare Utilization (Young Adult Survivors)Human papillomavirus (HPV) vaccine-Baseline: yes19 Participants
Randomized Control Trial Participants-Young Adult SurvivorsHealthcare Utilization (Young Adult Survivors)Mammogram-Time 3: yes1 Participants
Randomized Control Trial Participants-Young Adult SurvivorsHealthcare Utilization (Young Adult Survivors)Human papillomavirus (HPV) vaccine-Time 3: yes19 Participants
Randomized Control Trial Participants-Young Adult SurvivorsHealthcare Utilization (Young Adult Survivors)Dental visit-Time 4: yes15 Participants
Randomized Control Trial Participants-Young Adult SurvivorsHealthcare Utilization (Young Adult Survivors)Human papillomavirus (HPV) vaccine-Time4: yes20 Participants
Randomized Control Trial Participants-Young Adult SurvivorsHealthcare Utilization (Young Adult Survivors)Mammogram-Time 4: yes1 Participants
Usual CareHealthcare Utilization (Young Adult Survivors)Human papillomavirus (HPV) vaccine-Time4: yes17 Participants
Usual CareHealthcare Utilization (Young Adult Survivors)Dental visit-Time 4: yes13 Participants
Usual CareHealthcare Utilization (Young Adult Survivors)Survivorship Care Plan-Baseline : yes10 Participants
Usual CareHealthcare Utilization (Young Adult Survivors)Survivorship Care Plan-Time 3 : yes15 Participants
Usual CareHealthcare Utilization (Young Adult Survivors)Survivorship Care Plan-Time 4 : yes11 Participants
Usual CareHealthcare Utilization (Young Adult Survivors)Annual survivorship visit-Baseline: yes16 Participants
Usual CareHealthcare Utilization (Young Adult Survivors)Annual survivorship visit-Time 3: yes1 Participants
Usual CareHealthcare Utilization (Young Adult Survivors)Annual survivorship visit-Time 4: yes9 Participants
Usual CareHealthcare Utilization (Young Adult Survivors)Echocardiogram-Baseline: yes15 Participants
Usual CareHealthcare Utilization (Young Adult Survivors)Echocardiogram-Time 3: yes16 Participants
Usual CareHealthcare Utilization (Young Adult Survivors)Echocardiogram-Time 4: yes13 Participants
Usual CareHealthcare Utilization (Young Adult Survivors)Mammogram-Baseline: yes1 Participants
Usual CareHealthcare Utilization (Young Adult Survivors)Mammogram-Time 3: yes1 Participants
Usual CareHealthcare Utilization (Young Adult Survivors)Mammogram-Time 4: yes0 Participants
Usual CareHealthcare Utilization (Young Adult Survivors)Skin cancer screening-Baseline: yes5 Participants
Usual CareHealthcare Utilization (Young Adult Survivors)Skin cancer screening-Time 3: yes7 Participants
Usual CareHealthcare Utilization (Young Adult Survivors)Skin cancer screening-Time 4: yes7 Participants
Usual CareHealthcare Utilization (Young Adult Survivors)Primary care visit-Baseline: yes24 Participants
Usual CareHealthcare Utilization (Young Adult Survivors)Primary care visit-Time 3: yes22 Participants
Usual CareHealthcare Utilization (Young Adult Survivors)Primary care visit-Time 4: yes21 Participants
Usual CareHealthcare Utilization (Young Adult Survivors)Dental visit-Baseline: yes21 Participants
Usual CareHealthcare Utilization (Young Adult Survivors)Annual flu vaccine-Baseline12 Participants
Usual CareHealthcare Utilization (Young Adult Survivors)Annual flu vaccine-Time 317 Participants
Usual CareHealthcare Utilization (Young Adult Survivors)Annual flu vaccine-Time 416 Participants
Usual CareHealthcare Utilization (Young Adult Survivors)Human papillomavirus (HPV) vaccine-Baseline: yes16 Participants
Usual CareHealthcare Utilization (Young Adult Survivors)Human papillomavirus (HPV) vaccine-Time 3: yes16 Participants
Usual CareHealthcare Utilization (Young Adult Survivors)Dental visit-Time 3: yes17 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026